The mechanism of action is fundamentally different, targeting incretin receptors in the pancreas, brain, and gut rather than the kidneys
First-month weight loss depends on starting dose, baseline metabolism, genetics, diet quality, and exercise
Yes , retatrutide will be available as a once-weekly self-injectable medication, similar to other weight loss injections
The GLP-1 and breastfeeding guide covers the nuances of this topic, but the general recommendation is to stop GLP-1 treatment at least 2 months before attempting conception due to the long half-life
In late-stage trials, people taking orforglipron lost an average of about 12% of their body weight over roughly 72 weeks , and head-to-head studies suggest it may outperform standard oral semaglutide tablets (Rybelsus) in both weight loss and blood sugar control
Simpler serving sizes and easy-to-use formats may feel more manageable throughout the day